Cyclacel Pharmaceuticals has declared a quarterly cash dividend of $0.15 per share for its 6% Convertible Exchangeable Preferred Stock. According to the company, the dividend is set to be paid on May 1, 2025, with stockholders of record as of April 29, 2025, eligible to receive the payment.
Cyclacel Pharmaceuticals, a biopharmaceutical company listed on NASDAQ under the ticker CYCC, has a market capitalization of approximately $47 million. It trades at $0.23 per share and notably does not pay dividends to its common stockholders. However, despite the dividend announcement, the company's financial health raises concerns as its stock has plummeted nearly 83% over the past six months. Additionally, it has a current ratio of 0.59, indicating liabilities exceed current liquid assets, as reported by Insider Monkey.
The company has not committed to continuing the dividend payments into future quarters. This decision is dependent on Cyclacel's financial state and other market factors, and no assurance can be given regarding future distributions. The company's recent challenges are evident, influencing its strategic financial planning moving forward.